1. Adegbite AB, Khan MI, Paine KWE, Tan LK: The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 58: 51-56, 1983 2. Akagi K, Kurahashi H, Arita N, Hayakawa T, Monden M, Mori T, Takai SI, Nishisho I: Deletion mapping of the long arm of chromosome 22 in human meningiomas. Int J Cancer 60: 178-182, 1995 3. Barbaro NM, Gutin PH, Wilson CB, Sheline GE, Boldrey EB, Wara WM: Radiation therapy in the treatment of partially resected meningiomas. Neurosurgery 20: 525-528 (1987) 4. Beks JWF, DeWindt HL: The recurrence of supratentorial meningiomas after surgery. Acta Neurochir (Vienna) 95: 3-5, 1988 5. Bello MJ, de Campos JM, Kusak ME, Vaquero J, Sarasa JL, Pestana A, Rey: Allelic loss of 1p is associated with tumor progression of meningiomas. Genes Chromosomes Cancer 9: 296-298, 1994 6. Borovich B, Doron Y: Recurrence of intracranial meningiomas: the role played by regional multicentricity. J Neurosurg 64: 58-63, 1986 7. Casalone R, Simi P, Granata P, Minelli E, Giudici A, Butti G, Solero CL: Correlation between cytogenetic and histopathological findings in 65 human meningiomas. Cancer Genet Cytogenet 45: 237-243, 1990 8. Chan RC, Thompson GB: Morbidity, mortality, and quality of life following surgery for intracranial meningiomas. A retrospective study in 257 cases. J Neurosurg 60: 52-60, 1984 9. Codd MB, Kurland LT: Descriptive epidemiology of primary intracranial neoplasms. Prog Exp Tumor Res 29: 1-11, 1985 10. Cushing H, Eisenhardt L: Meningiomas: their classification, regional behaviour, life history, and surgical end results, Hafner, New York, 1938 11. DeMonte F: Current management of meningiomas. Oncol 9: 83-96, 1995 12. Doco-Fenzy M, Cornillet P, Scherpereel B, Depernet B, Bisiau-Leconte S, Ferre D, Pluot M, Graftiaux JP, Teyssier JR: Cytogenetic changes in 67 cranial and spinal meningiomas: relation to histopathological and clinical pattern. Anticancer Res 13: 845-850, 1993 13. Glaholm J, Bloom HJG, Crow JH: The role of radiotherapy in the management of intracranial meningiomas: The Royal Marsden Hospital experience with 186 patients. Int J Radiat Oncol Biol Phys 18: 755-761, 1990 14. Goldsmith BJ, Wara WM, Wilson CB, Larson DA: Postoperative irradiation for subtotally resected meningiomas. J Neurosurg 80: 195-201, 1994 15. Henn W, Cremerius U, Heide G, Lippitz B, Schröder JM, Gilsbach JM, Büll U, Zang KD: Monosomy 1p is correlated with enhanced in vivo glucose metabolism in meningiomas. Cancer Genet Cytogenet 79: 144-148, 1995 16. Harrison MJ, Sundaresan N: Radiation induced meningiomas. In: H. H. Schmidek (Hrsg.) Meningiomas and their surgical management. Saunders, Philadelphia, 1992 17. Ildan F, Tuna M, Göçer AI, Boyar B, Bagdatoglu H, Sen O, Haciyakupoglu S, Burgut R: Correlation of the relationships of brain-tumor interfaces, magnetic resonance imaging, and angiographic findings to predict cleavage of meningiomas. J Neurosurg 91: 384-390, 1999 18. Jääskeläinen J, Haltia M, Servo A: Atypical and anaplastic meningiomas: Radiology, surgery, radiotherapy and outcome. Surg Neurl 25: 233-242, 1986 19. Jellinger K, Slowik: Histological subtypes and prognostic problems in meningioma. J Neurol 208: 279-298, 1975 20. Jellinger K: Histopathological features predicting recurrence of meningiomas after (sub)total resection. Clin Neuropathol 7: 174, 1988 21. Ketter R, Henn W, Niedermayer I, Steilen-Gimbel H, König J, Zang KD, Steudel WI: Predictive value of progression-associated chromosomal aberrations for the prognosis of meningiomas: a retrospective study of 198 cases. J Neurosurg 95(4): 601-7, 2001 22. Kleihues P, Burger PC, Scheithauer BW: The new WHO classification of brain tumors. Brain Pathol 3: 255-268, 1993 23. Kolles H, Niedermayer I, Schmitt Ch, Henn W, Feld R, Steudel WI, Zang KD, Feiden W: Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics. Acta Neurochir (Vienna) 137: 174-181, 1995 24. Langford LA: Pathology of meningiomas. J Neurooncol 29: 217-221, 1996 25. Limon J, Dal-Cin P, Sandberg AA: Application of long-term collagenase disaggregation for the cytogenetic analysis of human solid tumors. Cancer Genet Cytogenet 23: 305-313, 1986 26. Lopez GC, Cerda NM, Bracia SJL, Llombart BA: Cytogenetical findings of recurrent meningiomas. A study of 10 tumors. Cancer Genet Cytogenet 85: 113-117, 1995 27. Mahmood A, Qureshi NH, Malik GM: Intracranial menigiomas: Analysis of recurrence after surgical treatment. Acta Neurochir (Vienna) 126: 53-58, 1994 28. Mahmood A, Caccamo DV, Tomecek FJ, Malik GM: Atypical and malignant meningiomas: a clinicopathological review. Neurosurgery 33: 955-963, 1993 29. Mantle RE, Lach B, Delgado MR, Baeesa S, Bélanger G: Predicting the probability of meningioma recurrence based on the quantity of peritumoral brain edema on computerized tomography scanning. J Neurosurg 91: 375-386, 1999 30. Matsuura S, Kishi F, Kajii T: Characterization of a 5?-flanking region of the human liver/bone/kidney alkaline phosphatase gene. Biochem Biophys Res Commun 168: 993-1000, 1990 31. McCarthy BJ, Davis FG, Freels S, Surawicz TS, Damek DM, Grutsch J, Meneck HR, Lawser JR: Factors associated with survival in patients with meningioma. J Neurosurg 88: 831-839, 1998 32. McCutcheon IE: The biology of meningiomas. J Neurooncol 29: 207-216, 1996 33. McLean CA, Jolley D, Cukier E, Giles G, Gonzales MF: Atypical and malignant meningiomas: importance of micronecrosis as a prognostic indicator. Histopathology 23: 349-353, 1993 34. Menon GM, Rutter JL, von Sattel JP, Synder H, Murdoch C, Blumenfeld A, Martuza RL, von Deimling A, Gusella JF, Houseal TW: Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative "tumor progression" locus. Oncogene 14: 611-616, 1997. 35. Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL: Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 62: 18-24, 1985 36. Moller ML, Braendstrup o: No prediction of recurrence of meningiomas by PCNA and KI-67 immunohistochemistry. J Neurooncol 34: 241-246, 1997 37. Mueller P, Henn W, Niedermayer I, Ketter R, Feiden W, Steudel WI, Zang KD, Steilen-Gimbel H: Deletion of chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas. Clin Cancer Res 5: 3569-3577, 1999 38. Niedermayer I, Kolles H, Zang KD, Feiden W: Characterization of intermediate type (WHO "atypical") meningiomas. Clin Neuropathol 15: 330-336, 1996 39. Niedermayer I, Kolles H, Henn W, Zang KD, Steudel WI, Feiden W. [Meningioma. Classification and grading] Pathologe. 18(5): 353-8, 1997b 40. Niedermayer I, Feiden W, Henn W, Steilen-Gimbel H, Steudel WI, Zang KD: Loss of alkaline phosphatase activity in meningiomas: a rapid histochemical technique indicating progression-assoziated deletion of a putative tumor suppressor gene on the distal part of the short arm of chromosome 1. J Neuropathol Exp Neurol 56: 879-886, 1997a 41. Palma L, Celli P, Franco C, Cervoni L, Cantore G: Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases. J Neurosurg 86: 793-800, 1997 42. Perry A, Jenkins RB, Dahl RJ, Moertel CA, Scheithauer BW: Cytogenetic analysis of aggressive meningiomas. Cancer 77: 2567-2573, 1996 43. Perry A, Stafford SL, Scheidhauer BW, Suman VJ, Lohse CM: Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 21: 1455-1465, 1997 44. Petty AM, Kun LE, Meyer GA: Radiation therapy for incompletely resected meningiomas. J Neurosurg 62: 502-507, 1985. 45. Preston-Martin S., Paganini-Hill A., Henderson BE. et al.: Case control study of intracranial meningiomas in women in Los Angeles County. J Natl Cancer Inst 65: 67-73, 1980 46. Prowald A, Vater K, Ketter R, Freiler A, Henn W, Zang KD, Steudel W-I: Down-regulation of the expression of tissue-unspecific alkaline phosphatase enzyme (EC 3.1.3.1) during the progression of meningioma, Berichte aus der Medizin, 2002a 47. Prowald A, Vater K, Ketter R, Henn W, Zang KD, Steudel W-I: Analysis of the human liver/bone/kidney type alkaline phosphatase gene in meningiomas, J Cancer Res Clin Oncol 128 (supplement 1): 99, 2002b 48. Roggendorf W, Schuster T, Pfeiffer J: Proliferative potential of meningiomas determined with the monoclonal antibody Ki-67. Acta Neuropathol 73: 361-364, 1987 49. Rohringer M, Sutherland GR, Louw DF, Sima AAF: Incidence and clinicopathological features of meningioma. J Neurosurg 71: 665-672, 1989 50. Saadi AA, Latimer F, Madercic M, Robbins T: Cytogenetic studies of human brain tumors and their clinical significance. II. Meningioma. Cancer Genet Cytogenet 26: 127-141, 1987 51. Scheithauer BW: Tumors of the meninges: proposed modifications of the World Health Organisation classification. Acta Neuropathol 80: 343-354, 1990 52. Seabright: A rapid banding technique for human chromosomes. Lancet 2: 971-972, 1971 53. Simon M, von Deimling A, Larson JJ, Wellenreuter R, Kaskel P, Waha A, Warnick RE, Tew JR, JM, Menon AG: Allelic loss on chromosomes 14, 10 and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression. Cancer Res 55: 4696-4701, 1995 54. Simpson D: The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20: 22-39, 1957 55. Soffer D, Pittaluga S, Feiner M, Beller AJ: Intracranial meningiomas following low-dose irradiation to the head. J Neurosurg 59: 1048-1053, 1983 56. Steilen-Gimbel H, Niedermayer I, Feiden W, Freiler A, Steudel WI, Zang KD, Henn W: Unbalanced translocation t(1;3)(p12-13;q11) in meningiomas as the unique feature of chordoid differentiation. Genes Chromosomes Cancer: 26(3):270-2, 1999 57. Steudel WI, Feld R, Henn W, Zang KD: Correlation between cytogenetic and clinical findings in 215 human meningiomas. Acta Neurochir [Suppl] 65: 73-76, 1996 58. Sutherland GR, Sima AA. : Incidence and clinicopathologic features of meningioma. In : H. H. Schmidek (Hrsg.) Meningiomas and their surgical management. Saunders Company, Philadelphia, 1992 59. Takeuchi H, Kubota T, Kabuto M, Kitai R, Nozaki J, Yamashita J: Prediction of recurrence in histologically benign meningiomas: proliferating cell nuclear antigen and Ki-67 immunohistochemical study. Surg Neurol 48: 501-506, 1997 60. Taylor BW, Marcus RB, Friedman WA, Ballinger WE, Million RR: The meningioma controversy: postoperative radiation therapy. Int J Radiat Oncol Biol Phys 15: 299-304 (1988) 61. Wara WM, Sheline GE, Newman M, Townsend JJ, Boldrey EB: Radiation therapy of meningiomas. Am J Roentgenol 123: 453-458 (1975) 62. Weber RG, Boström J, Wolters M, Baudis M, Collins P, Reifenberger G, Lichter P: Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: Toward a genetic model of meningioma progression. Proc Natl Acad Sci USA Vol. 94: 14719-14724, 1997. 63. Weber GA, Sass C, Ketter R, Henn W, Steudel W-I, Zang KD: Mikrodissektion an Alkalische Phosphatase gefärbten Meningeomschnitten zur CGH Analyse.Berichte aus der Medizin, 2002 64. Weiss M, Ray K, Henthorn P, Lamb B, Kadesch T, Harris H: Structure of the human liver/bone/kidney alkaline phosphatase gene. J Biol Chem 263: 12002-12010, 1988 65. Younis GA, Sawaya R, Demonte F, Hess KR, Albrecht S, Brunner JM: Aggressive meningeal tumors: review of a series. J Neurosurg 82:17-27, 1995 66. Zang KD: Cytological and cytogenetical studies on human meningioma. Cancer Genet Cytogenet 6: 249-274, 1982 67. Zang KD, Singer H: Chromosomal constitution of meningiomas. Nature 216: 84-85, 1967 68. Zang KD: Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases. Cytogenet Cell Genet 93(3-4): 207-20, 2001 69. Zankl H, Zang KD: Correlation between clinical and cytogenetical data in 180 human meningiomas. Cancer Genet Cytogenet 1: 351-356, 1980 70. Zülch KJ: Histological typing of tumors of the central nervous system. Geneva, World Health Organisation 1979 71. Zülch KJ: Biologie und Pathologie der Hirngeschwuelste. In: Handbuch der Neurochirurgie, Bd. 3. Springer-Verlag Berlin, Goettingen, Heidelberg 1956
Wichtige Übersichtsarbeiten
Ketter R, Henn W, Niedermayer I, Steilen-Gimbel H, König J, Zang KD, Steudel WI: Predictive value of progression-associated chromosomal aberrations for the prognosis of meningiomas: a retrospective study of 198 cases. J Neurosurg 95(4): 601-7, 2001
Zang KD: Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases. Cytogenet Cell Genet 93(3-4): 207-20, 2001
|
